Rising Demand For Thin Film Drug Delivery Systems Fueling Growth In The Oral Thin Film Market: A Significant Driver Propelling The Oral Thin Films Market In 2025

The Oral Thin Films Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Oral Thin Films Market Size and Projected Growth Rate?
The market size for oral thin films has experienced substantial growth lately. Its value is expected to increase from $4.48 billion in 2024 to $5.03 billion in 2025, boasting a compound annual growth rate (CAGR) of 12.2%. The surge in growth during the past years is linked to factors such as patient compliance, utilization by pediatric and geriatric patients, swift drug delivery, prevalence of chronic diseases, and the use of over-the-counter (otc) medications.

The size of the market for oral thin films is anticipated to expand swiftly in the forthcoming years, reaching a projected total of $8.72 billion in 2029 alongside a compound annual growth rate (CAGR) of 14.7%. This increase throughout the forecast period can be linked to factors such as specialty pharmaceuticals, precision medicine, mental health drugs, oral vaccines, and telemedicine services. The forecast period also forecasts trends such as drug delivery technologies, remote care, improvements in bioavailability, usage during travel and on-the-move, and formulations devoid of allergens.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6067

What Are the Major Segments in the Oral Thin Films Market?
The oral thin films market covered in this report is segmented -

1) By Type: Sublingual Film, Fast Dissolving Dental/Buccal Film
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indication
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments:
1) By Sublingual Film: Drug Delivery Films, Nutritional Supplement Films
2) By Fast Dissolving Dental Or Buccal Film: Over-the-Counter (OTC) Products, Prescription Products

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6067&type=smp

What Are The Driving Oral Thin Films Market Evolution?
The surging need for thin film drug delivery systems is fuelling the expansion of the oral thin film market. Thin films are viewed as a potential substitute to conventional dosage forms. They offer a convenient, self-administrative and quick-dissolving mechanism for medication delivery, establishing them as a flexible drug delivery platform. Thin films have oral administration and don't require water for drug absorption. Oral Thin Film (OTF) is more favourable to patients due to its quick dissolution rate. These factors are increasing the demand for thin film drug delivery systems and consequently escalating the demand for oral thin films. Heart disease affects over half the population in the United States. In January 2023, The American Cancer Society, a US-based non-profit organization, reported that at least 42% of fresh cancer diagnoses in the US, apart from non-melanoma skin cancer, contributed to around 820,000 cases in 2023 and 840,000 cases in 2024. These numbers underscore the rising necessity for advanced drug delivery methods to secure efficient treatment. Hence, the increasing demand for thin film drug delivery systems is propelling the growth of the oral thin film market.

Which Firms Dominate The Oral Thin Films Market Segments?
Major companies operating in the oral thin films market include ZIM Laboratories Limited, NAL Pharma, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., Sunovion Pharmaceuticals Inc., Seoul Pharma Co. Ltd., Aquestive Therapeutics Inc., Shilpa Therapeutics Pvt. Ltd., Mylan Inc., LIVKON Pharmaceuticals Pvt. Ltd., Panacea Biotec Ltd., Adare Pharmaceuticals Inc., APR Applied Pharma Research SA, BioDelivery Sciences International Inc., Sumitomo Dainippon Pharma Co. Ltd., Indivior PLC, LTS Lohmann Therapie-Systeme AG, Tesa Labtec GmbH, Pfizer Inc., Sanofi S.A., Merck & Co. Inc., Novartis International AG, Roche Holding AG, Johnson & Johnson, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, AbbVie Inc., Bristol-Myers Squibb Company, Novo Nordisk A/S, AstraZeneca plc

What Trends Are Expected to Dominate the Oral Thin Films Market in the Next 5 Years?
Leading firms in the oral thin films market are leveraging innovative products like Rizaport to boost their market revenues. Rizaport is a proprietary oral thin-film formulation that includes rizatriptan benzoate, a 5-HT1 receptor agonist and the active component in Merck & Co.'s Maxalt. For example, in February 2024, the US-based drug formulation business, CD Formulation, introduced its oral thin film technology. It is tailored to patient-friendly use, particularly for those who encounter difficulties swallowing. It ensures rapid absorption by dissolving in the oral cavity, sidestepping the digestive system to accelerate the onset of action. This ground-breaking drug delivery system heightens bioavailability, provides accurate dosing for personalized treatment, and enhances convenience and medication adherence, especially under emergency circumstances.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

Which Is The Largest Region In The Oral Thin Films Market?
North America was the largest region in the oral thin film market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral thin films market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Oral Thin Films Market?
2. What is the CAGR expected in the Oral Thin Films Market?
3. What Are the Key Innovations Transforming the Oral Thin Films Industry?
4. Which Region Is Leading the Oral Thin Films Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.